Skip to main content
. Author manuscript; available in PMC: 2014 Sep 9.
Published in final edited form as: JAMA Intern Med. 2013 Sep 9;173(16):1514–1521. doi: 10.1001/jamainternmed.2013.8725

Table 2.

Mortality, Major Medical Complications, and Resource Utilization.

No. (%)
Control
(n = 115 851)
Augmented
(n = 10 541)
HR or OR
(95% CI)
P
Value
Death
  30 days 1754 (1.5) 39 (0.4) 0.29 (0.20–0.41) <.001
  1 year 7768 (6.7) 546 (5.2) 0.83 (0.75–0.92) <.001
Major medical complication
  30 days 12 057 (10.4) 975 (9.3) 0.85 (0.79–0.92) <.001
  1 year 33 497 (28.9) 3051 (28.9) 1.00 (0.95–1.04) .90
Healthcare utilization (1 year)
  Hospitalizationa 55 164 (47.6) 6324 (60.0) 1.37 (1.30–1.44) <.001
  ICU admission 13 247 (11.4) 1470 (13.9) 1.14 (1.06–1.21) <.001
  SNF discharge 19 819 (17.1) 2284 (21.7) 1.16 (1.10–1.23) <.001
  Wrist fracture 2387 (2.1) 194 (1.8) 0.90 (0.76–1.07) .23
  Hip fracture 7664 (6.6) 677 (6.4) 0.96 (0.87–1.05) .37

No Procedure (30 days) Control
(n = 115 851)
Pre-Procedureb
(n = 3023)

Major medical complications 12 057 (10.4) 199 (6.6) 0.66 (0.57–0.78) <.001

Abbreviations: CI, confidence interval; HR, hazard ratio; ICU, Intensive care unit; OR, Odds ratio; SNF, skilled nursing facility.

a

Hospitalizations after vertebral fracture diagnosis and excluding hospitalization at the time of spinal augmentation procedure.

b

Pre-procedure subgroup includes patients from the augmented group who had not yet undergone spinal augmentation at 30 days.